AgeX Therapeutics
Organisation
Funding rounds
Form D
US$4.5m, 11 Mar 2019
Form D
US$200k, 15 Aug 2018
Form D
US$5m, 6 Jun 2018
Form D
US$462.5k, 16 Jan 2018
Form D
US$8.9m, 23 Jun 2017
Sources: sec.gov
Deals
Financing
Roth Principal Investments, LLC, US$25m, 27 Aug 2026
Financing
US$15m, 23 Mar 2026
Financing
US$13.3m, 29 Apr 2025
Financing
US$5m, 14 Apr 2025
Acquisition
26 Dec 2024
Financing
ReCyte Therapeutics, Inc., US$9.3m, 1 Apr 2024
Merger, 30 Aug 2023
Financing, 21 Jul 2023
Merger
15 Mar 2023
Sources: sec.gov
Investors
Sources: agingbio.app
Competes in
Sources: lifespan.io